Hyperfine, Inc.
HYPR- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001833769
In the last 90 days, Hyperfine, Inc. insiders filed 0 open-market purchases and 2 sales; 80 institutions reported holding it in 13F filings for Q2 2026, worth $29.4M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Hyperfine, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 51 | 47 | −4 |
| Shares | 10.8M | 10.6M | −154.3K (−1.4%) |
| Value | $12.1M | $10.6M | −$1.45M (−12.0%) |
New holders (1)
Institutions that held Hyperfine, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Barclays PLC | 45,000 | $45.0K | 0.00% |
Sold out (5)
Institutions that held Hyperfine, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| XTX Topco Ltd | 39,425 | $44.2K |
| Two Sigma Advisers, LP | 10,500 | $11.8K |
| Rhumbline Advisers | 4,588 | $5.14K |
| Simplex Trading, LLC | 1,105 | $1.00K |
| Bank of America Corp | 33 | $37 |